12:00 AM
 | 
Nov 01, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Results

GVAX: Phase I data; Phase II

CEGE published in Cancer Research results of an 11-patient Phase I study with the autologous form of GVAX. Expansion of autologous cells was sufficient to treat 8...

Read the full 113 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >